These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 33630216)

  • 1. Increased Use of Prophylactic Measures in Preventing Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis.
    Sperna Weiland CJ; Engels MML; Poen AC; Bhalla A; Venneman NG; van Hooft JE; Bruno MJ; Verdonk RC; Fockens P; Drenth JPH; van Geenen EJM;
    Dig Dis Sci; 2021 Dec; 66(12):4457-4466. PubMed ID: 33630216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-steroidal anti-inflammatory drugs, intravenous fluids, pancreatic stents, or their combinations for the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis: a systematic review and network meta-analysis.
    Akshintala VS; Sperna Weiland CJ; Bhullar FA; Kamal A; Kanthasamy K; Kuo A; Tomasetti C; Gurakar M; Drenth JPH; Yadav D; Elmunzer BJ; Reddy DN; Goenka MK; Kochhar R; Kalloo AN; Khashab MA; van Geenen EJM; Singh VK
    Lancet Gastroenterol Hepatol; 2021 Sep; 6(9):733-742. PubMed ID: 34214449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Universal prophylactic rectal nonsteroidal anti-inflammatory drugs with a policy of selective pancreatic duct stenting significantly reduce post-endoscopic retrograde cholangiopancreatography  pancreatitis.
    Agarwal A; Mahapatra SJ; Sethia R; Agarwal S; Elhence A; Mohta S; Gunjan D; Garg PK
    Indian J Gastroenterol; 2023 Jun; 42(3):370-378. PubMed ID: 37160838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aggressive fluid hydration plus non-steroidal anti-inflammatory drugs versus non-steroidal anti-inflammatory drugs alone for post-endoscopic retrograde cholangiopancreatography pancreatitis (FLUYT): a multicentre, open-label, randomised, controlled trial.
    Sperna Weiland CJ; Smeets XJNM; Kievit W; Verdonk RC; Poen AC; Bhalla A; Venneman NG; Witteman BJM; da Costa DW; van Eijck BC; Schwartz MP; Römkens TEH; Vrolijk JM; Hadithi M; Voorburg AMCJ; Baak LC; Thijs WJ; van Wanrooij RL; Tan ACITL; Seerden TCJ; Keulemans YCA; de Wijkerslooth TR; van de Vrie W; van der Schaar P; van Dijk SM; Hallensleben NDL; Sperna Weiland RL; Timmerhuis HC; Umans DS; van Hooft JE; van Goor H; van Santvoort HC; Besselink MG; Bruno MJ; Fockens P; Drenth JPH; van Geenen EJM;
    Lancet Gastroenterol Hepatol; 2021 May; 6(5):350-358. PubMed ID: 33740415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rectal nonsteroidal anti-inflammatory drugs are superior to pancreatic duct stents in preventing pancreatitis after endoscopic retrograde cholangiopancreatography: a network meta-analysis.
    Akbar A; Abu Dayyeh BK; Baron TH; Wang Z; Altayar O; Murad MH
    Clin Gastroenterol Hepatol; 2013 Jul; 11(7):778-83. PubMed ID: 23376320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NSAIDs for prevention of pancreatitis after endoscopic retrograde cholangiopancreatography: ready for prime time?
    Parsi MA
    World J Gastroenterol; 2012 Aug; 18(30):3936-7. PubMed ID: 22912542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis: a cost-effectiveness analysis.
    Nicolás-Pérez D; Castilla-Rodríguez I; Gimeno-García AZ; Romero-García R; Núñez-Díaz V; Quintero E
    Pancreas; 2015 Mar; 44(2):204-10. PubMed ID: 25406954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prophylaxis of post-ERCP pancreatitis: European Society of Gastrointestinal Endoscopy (ESGE) Guideline - updated June 2014.
    Dumonceau JM; Andriulli A; Elmunzer BJ; Mariani A; Meister T; Deviere J; Marek T; Baron TH; Hassan C; Testoni PA; Kapral C;
    Endoscopy; 2014 Sep; 46(9):799-815. PubMed ID: 25148137
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized controlled trial of pancreatic stenting to prevent pancreatitis after endoscopic retrograde cholangiopancreatography.
    Kawaguchi Y; Ogawa M; Omata F; Ito H; Shimosegawa T; Mine T
    World J Gastroenterol; 2012 Apr; 18(14):1635-41. PubMed ID: 22529693
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prophylaxis of Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis Using Temporary Pancreatic Stents Versus Rectal Nonsteroidal Anti-inflammatory Drugs: A Randomized Controlled Trial.
    Koshitani T; Konaka Y; Ohishi T; Yasuda T; Morinushi T; Mita M; Masuda M; Nakano K; Fuki S; Nakagawa S
    Pancreas; 2022 Jul; 51(6):663-670. PubMed ID: 36099496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prophylaxis of post-ERCP pancreatitis: a practice survey.
    Dumonceau JM; Rigaux J; Kahaleh M; Gomez CM; Vandermeeren A; Devière J
    Gastrointest Endosc; 2010 May; 71(6):934-9, 939.e1-2. PubMed ID: 20226455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Practice patterns of post-ERCP pancreatitis prophylaxis techniques in the United States: a survey of advanced endoscopists.
    Avila P; Holmes I; Kouanda A; Arain M; Dai SC
    Gastrointest Endosc; 2020 Mar; 91(3):568-573.e2. PubMed ID: 31743690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective biliary cannulation techniques for endoscopic retrograde cholangiopancreatography procedures and prevention of post- endoscopic retrograde cholangiopancreatography pancreatitis.
    Mukai S; Itoi T
    Expert Rev Gastroenterol Hepatol; 2016 Jun; 10(6):709-22. PubMed ID: 26782710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors for post-ERCP pancreatitis in high risk patients who have undergone prophylactic pancreatic duct stenting: a multicenter retrospective study.
    Ito K; Fujita N; Kanno A; Matsubayashi H; Okaniwa S; Nakahara K; Suzuki K; Enohara R;
    Intern Med; 2011; 50(24):2927-32. PubMed ID: 22185981
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Can pancreatic duct stenting prevent post-ERCP pancreatitis in patients who undergo pancreatic duct guidewire placement for achieving selective biliary cannulation? A prospective randomized controlled trial.
    Ito K; Fujita N; Noda Y; Kobayashi G; Obana T; Horaguchi J; Takasawa O; Koshita S; Kanno Y; Ogawa T
    J Gastroenterol; 2010 Nov; 45(11):1183-91. PubMed ID: 20607310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Post-ERCP pancreatitis: review of current preventive strategies.
    Feurer ME; Adler DG
    Curr Opin Gastroenterol; 2012 May; 28(3):280-6. PubMed ID: 22450899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of pancreatic duct stenting to prevent postendoscopic retrograde cholangiopancreatography pancreatitis after covered self-expandable metal stent deployment.
    Toyonaga H; Hayashi T; Yamazaki H; Hama K; Iwano K; Nakamura R; Ando R; Shimizu T; Ishii T; Kin T; Takahashi K; Katanuma A
    Dig Endosc; 2023 Mar; 35(3):369-376. PubMed ID: 36129765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pancreatic duct stenting for the duration of ERCP only does not prevent pancreatitis after accidental pancreatic duct cannulation: a prospective randomized trial.
    Conigliaro R; Manta R; Bertani H; Manno M; Barbera C; Caruso A; Olivetti G; Melotti G; Frazzoni M
    Surg Endosc; 2013 Feb; 27(2):569-74. PubMed ID: 22926890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Post-ERCP pancreatitis.
    Arata S; Takada T; Hirata K; Yoshida M; Mayumi T; Hirota M; Yokoe M; Hirota M; Kiriyama S; Sekimoto M; Amano H; Wada K; Kimura Y; Gabata T; Takeda K; Kataoka K; Ito T; Tanaka M
    J Hepatobiliary Pancreat Sci; 2010 Jan; 17(1):70-8. PubMed ID: 20012323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. European Society of Gastrointestinal Endoscopy (ESGE) Guideline: prophylaxis of post-ERCP pancreatitis.
    Dumonceau JM; Andriulli A; Deviere J; Mariani A; Rigaux J; Baron TH; Testoni PA;
    Endoscopy; 2010 Jun; 42(6):503-15. PubMed ID: 20506068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.